Volume 21, Number 11—November 2015
Research
Serotype Changes and Drug Resistance in Invasive Pneumococcal Diseases in Adults after Vaccinations in Children, Japan, 2010–2013
Table 5
Serotype (total no. isolates) | No. isolates, N = 92 | Penicillin resistance genotype | Macrolide resistance gene | Clonal complex | ST | Earliest report of same ST† |
|
---|---|---|---|---|---|---|---|
Year | Country (city) | ||||||
6C (17) | 1 | gPISP(pbp2x+2b) | erm(B) | 315 | 386 | 1996 | Portugal (Lisbon) |
4 | gPISP(pbp2x) | erm(B) | 2924 | 2924 | 2003 | Japan (Hyogo) | |
2 | gPISP(pbp2x) | erm(B) | 2924 | 6183 | 2008 | Japan (Kanagawa) | |
1 | gPISP(pbp2x) | erm(B) | 2924 | 9336‡ | 2012 | Japan (Fukuoka) | |
1 | gPSSP | Non | 473 | 473 | 1994 | England (Oxford) | |
3 | gPISP(pbp2x+2b) | erm(B) | 156 | 5241 | 2008 | Japan (Kumamoto) | |
2 | gPISP(pbp2x+2b) | mef(A) | 5832 | 5025‡ | 2012 | Japan (Kanagawa) | |
2 | gPISP(pbp2x+2b) | mef(A) or erm(B) | 5832 | 5832 | 2009 | Japan (Chiba) | |
1 |
gPISP(pbp2x+2b) |
mef(A)+erm(B) |
5832 |
5832 |
2009 |
Japan (Chiba) |
|
6D (1) |
1 |
gPRSP |
mef(A) |
81 |
282 |
1996; 2008 |
Vietnam [23F];
South Korea [6D] |
10A (11) | 1 | gPISP(pbp2x) | Non | 156 | 1263 | 1998 | USA (Arizona/New Mexico) |
1 | gPISP(pbp2x) | Non | 156 | 3395‡ | 2012 | Japan (Toyama) | |
8 | gPISP(pbp2x) | erm(B) | 113 | 5236 | 2007 | Japan (Kanagawa) | |
1 |
gPISP(pbp1a+2x) |
erm(B) |
113 |
3078‡ |
2012 |
Japan (Yamaguchi) |
|
11A (5) | 1 | gPSSP | mef(A) | 99 | 99 | 2007 | South Korea (Seoul) |
4 |
gPISP(pbp2x) |
mef(A)+erm(B) |
99 |
99 |
2007 |
South Korea (Seoul) |
|
15A (8) | 4 | gPISP(pbp1a+2x) | erm(B) | 63 | 63 | 1992 | [Sweden15A-25] |
4 |
gPRSP |
erm(B) |
63 |
63 |
1992 |
[Sweden15A-25] |
|
15B (6) | 1 | gPSSP | mef(A) | 199 | 199 | 1987 | [Netherlands15B-37] |
3 | gPISP(pbp2x) | erm(B) | 199 | 199 | 1987 | [Netherlands15B-37] | |
1 | gPISP(pbp2x) | erm(B) | 199 | 5609‡ | 2012 | Japan (Tokyo) | |
1 |
gPRSP |
erm(B) |
81 |
83 |
1997
2007 |
Taiwan [23F]
South Korea [15] |
|
15C (4) | 1 | gPISP(pbp2x) | erm(B) | 199 | 199 | 1987 | [Netherlands15B-37] |
2 | gPISP(pbp1a+2x) | erm(B) | 199 | 199 | 1987 | [Netherlands15B-37] | |
1 |
gPRSP |
erm(B) |
81 |
6138‡ |
2013 |
Japan (Tokyo) |
|
16F (1) |
1 |
gPRSP |
mef(A) |
3117 |
8351‡ |
2011 |
Japan (Mie) |
20 (3) |
3 |
gPSSP |
erm(B) |
4745 |
4745 |
2005 |
China (Wuhan, Hubei) |
22F (18) | 1 | gPSSP | Non | 433 | 433 | 1997 | Poland (center) |
4 | gPISP(pbp2x) | Non | 433 | 433 | 1997 | Poland (center) | |
10 | gPISP(pbp2x) | mef(A) or erm(B) | 433 | 433 | 1997 | Poland (center) | |
1 | gPISP(pbp2x) | mef(A) | 113 | 5236 | 2007 | Japan (Kanagawa) | |
2 |
gPISP(pbp2x) |
erm(B) |
113 |
7158 |
2007 |
Japan (Aichi) |
|
23A (9) | 2 | gPISP(pbp2x+2b) | erm(B) | 156 | 338 | 1995 | [Colombia23F-26] |
4 | gPISP(pbp2x+2b) | erm(B) | 156 | 5242 | 2009 | Japan (Kumamoto) | |
2 | gPISP(pbp2x+2b) | erm(B) | 156 | 5246 | 2008 | Japan (Niigata) | |
1 |
gPRSP |
erm(B) |
156 |
9619‡ |
2011 |
Japan (Toyama) |
|
35B (9) | 2 | gPSSP | erm(B) | 1816 | 2755 | 2004 | China (Shanghai) |
2 | gPISP(pbp2x) | mef(A) or erm(B) | 1816 | 2755 | 2004 | China (Shanghai) | |
1 | gPRSP | Non | 558 | 558 | 1999 | USA (New York) [35B] | |
4 | gPRSP | mef(A) or erm(B) | 558 | 558 | 1999 | USA (New York) [35B] |
*PCV13, 13-valent pneumococcal conjugate vaccine; ST, sequence type. Brackets in final column represent clones reported in the Pneumococcal Molecular Epidemiology Network Clone Collection (http://web1.sph.emory.edu/PMEN/index.html).
†Earliest year and first location are shown for the applicable ST registered in the Multilocus Sequence Typing website (http://spneumoniae.mlst.net).
‡Identified as a new ST in this study.
Page created: October 16, 2015
Page updated: October 16, 2015
Page reviewed: October 16, 2015
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.